DPIIT recognised startup Government of India
Startup India
Neurapy Private Limited - business services in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹33.76 Lakh
▼ 25% YoY
Net profit · FY 2024
₹7.15 Lakh
Net margin 21.2%
EBITDA · FY 2024
₹8.7 Lakh
EBITDA margin 25.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1.2 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Neurapy Private Limited
Data last updated:
Neurapy Private Limited is a private limited company based in Chennai, Tamil Nadu, India, recognised as a startup by DPIIT. It operates in the diversified business activities segment of the business services sector. It was incorporated on 20 September 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74999TN2018PTC124736. Its GSTIN is 33AAGCN2041M1ZK (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.2 Lakh. It is led by directors including Govindarajan Madan Kumar and Adithya Goyal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.49B D.No.8 M.G.R. Nagar Main Road Rajakilpakkam, Chennai, Tamil Nadu, India – 600073.
As per the financials filed for FY 2024, the company reported a revenue of ₹33.76 Lakh, a decline of 25% compared to the previous year. For the same year it recorded a net profit of ₹7.15 Lakh (net margin 21.2%) and EBITDA of ₹8.7 Lakh (EBITDA margin 25.8%). Revenue has grown at a compounded annual rate (CAGR) of 60% over three years and 38% over five years.
The company is associated with 1 brand: Neurapy.
For more details, the company can be reached via its website neurapy.com.
Company Details of Neurapy Private Limited
CIN U74999TN2018PTC124736
Registration Number 124736
Incorporation Date 20 September 2018
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Key People
Govindarajan Madan Kumar Director Adithya Goyal Director Kanchana Sankaranarayanan Director Recognitions & Rankings of Neurapy
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No.49B D.No.8 M.G.R. Nagar Main Road Rajakilpakkam, Chennai, Tamil Nadu, India – 600073
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
Comprehensive company report
Neurapy Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Neurapy Private Limited
Neurapy operates one associated brand: Neurapy. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides software for vision therapy to treat eye issues at home and clinics. | neurapy.com |
Business Activity of Neurapy Private Limited
The main business activity of Neurapy is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Neurapy Private Limited FY 2025 filings available
Neurapy Private Limited reported revenue of ₹33.76 Lakh (down 25% YoY) for FY 2024.
Revenue · FY 2024
₹33.76 Lakh ▼ 25%
Net profit · FY 2024
₹7.15 Lakh margin 21.2%
EBITDA · FY 2024
₹8.7 Lakh margin 25.8%
Compounded Annual Growth Rate (CAGR) of Neurapy Private Limited
Revenue CAGR growth
1 year
▼ 25%
3 years · compounded
▲ 60%
5 years · compounded
▲ 38%
EBITDA CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 116%
5 years · compounded
▲ 96%
Revenue fell 25% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 38%. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Neurapy Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹8.7 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹7.15 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Neurapy Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 25.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 21.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Neurapy are in the company report.
Premium access
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Neurapy Private Limited
Neurapy has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Govindarajan Madan Kumar | Director | 20 Sep 2018 | 8 Years 1 Months | Current |
| Adithya Goyal | Director | 20 Sep 2018 | 8 Years 1 Months | Current |
| Kanchana Sankaranarayanan | Director | 10 Feb 2025 | 1 Years 8 Months | Current |
Peer Comparison of Neurapy Private Limited
Neurapy Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Other professional, scientific and technical activities). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sakthi Diesel Service Private Limited | ₹33.79 Lakh (FY 2025) | •••• | •••• | -19.0% | •••• | Chennai, Tamil Nadu, India |
| Greek Alphabet Media Private Limited | ₹33.77 Lakh (FY 2025) | •••• | •••• | 72.0% | •••• | Pune, Maharashtra, India |
| Giekytribe Private Limited | ₹33.77 Lakh (FY 2025) | •••• | •••• | 210.0% | •••• | Rajpura, Punjab, India |
| Sysculus Systems Private Limited | ₹33.76 Lakh (FY 2025) | •••• | •••• | -2.0% | •••• | New Delhi, Delhi, India |
| Hydrotac Engineering Private Limited | ₹33.76 Lakh (FY 2025) | •••• | •••• | -34.0% | •••• | Aurangabad, Maharashtra, India |
| Neurapy Private Limited this company | ₹33.76 Lakh (FY 2024) | •••• | •••• | -25.0% | •••• | Chennai, Tamil Nadu, India |
| Chesmo Technologies Private Limited | ₹33.75 Lakh (FY 2024) | •••• | •••• | 341.0% | •••• | Chennai, Tamil Nadu, India |
| Tekvirtue Solutions Private Limited | ₹33.74 Lakh (FY 2024) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Durbin Technologies Private Limited | ₹33.73 Lakh (FY 2024) | •••• | •••• | -42.0% | •••• | Kolkata, West Bengal, India |
| Sge Associates Private Limited | ₹33.71 Lakh (FY 2025) | •••• | •••• | •••• | Chandigarh, India | |
| Tambridge Global Technology Solutions Private Limited | ₹33.71 Lakh (FY 2024) | •••• | •••• | -59.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Neurapy by revenue in the same principal business activity (Other professional, scientific and technical activities), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Neurapy Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Neurapy Private Limited
Neurapy Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Neurapy Private Limited
Employment history and EPFO contributions of people linked to Neurapy.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Neurapy Private Limited
Neurapy Private Limited has 5 board changes on record since 2018: 3 appointments and 2 cessations. The latest: Kanchana Sankaranarayanan ceased to be Additional Director on 29 Sep 2025.
AGM
Neurapy Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Kanchana Sankaranarayanan ceased to be Additional Director.
Filing
Neurapy Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Appointed
Kanchana Sankaranarayanan was appointed as Director.
Ceased
Jeya Polar Sudarson Pushparaja ceased to be Director.
Appointed
Adithya Goyal was appointed as Director.
Appointed
Govindarajan Madan Kumar was appointed as Director.
Incorporation
20 Sep 2018
Neurapy Private Limited was registered on 20 Sep 2018 with Roc Chennai & aged 8 years 1 month as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Neurapy Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Neurapy Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Neurapy Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Neurapy Private Limited
Neurapy has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAGCN2041M1ZK | Tamil Nadu | Active | 26 Oct 2018 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Neurapy Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neurapy Private Limited
Neurapy is an active private limited company based in Chennai, Tamil Nadu, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 20 September 2018 (8+ years old) and is registered under CIN U74999TN2018PTC124736.
Neurapy reported revenue of ₹33.76 Lakh for FY 2024 (down 25% YoY).
Neurapy has 3 current directors:
- Govindarajan Madan Kumar - Director
- Adithya Goyal - Director
- Kanchana Sankaranarayanan - Director
Neurapy reported a net profit of ₹7.15 Lakh (net margin 21.2%) and EBITDA of ₹8.7 Lakh (EBITDA margin 25.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Neurapy is 60% over three years and 38% over five years. In the latest year (FY 2024) revenue fell 25%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Neurapy is 33AAGCN2041M1ZK, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Neurapy is U74999TN2018PTC124736. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neurapy was incorporated on 20 September 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Neurapy by revenue are Sakthi Diesel Service Private Limited, Greek Alphabet Media Private Limited, Giekytribe Private Limited, Sysculus Systems Private Limited, Hydrotac Engineering Private Limited and 5 more, all in the same principal business activity (Other professional, scientific and technical activities).
Kanchana Sankaranarayanan ceased to be Additional Director on 29 Sep 2025. Kanchana Sankaranarayanan was appointed as Director on 10 Feb 2025. Jeya Polar Sudarson Pushparaja ceased to be Director on 07 Feb 2025. Neurapy has 5 board changes on record in total.
Yes, Neurapy is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).